Status:

COMPLETED

COVID-19 Vaccination Uptake in Belgium : Sociodemographic and Socioeconomic Disparities

Lead Sponsor:

Sciensano

Conditions:

COVID-19

Eligibility:

All Genders

18+ years

Brief Summary

In January 2021, the vaccination campaign against coronavirus disease 2019 (COVID-19) started in Belgium. The vaccination campaign was conducted in several phases, with the first phase targeting prior...

Detailed Description

1. Study design and data sources In this retrospective cohort study, the investigators aimed to unravel SE and SD disparities in the uptake of the first COVID-19 vaccine dose using data from the L...

Eligibility Criteria

Inclusion

  • Inclusion criteria :
  • Tested at least once in Belgium before 31 August 2021
  • Exclusion criteria :
  • people with a national registry status equivalent to deceased
  • people with a national registry status equivalent to migrated
  • people with a national registry status equivalent to deregistered
  • people with an unknown age
  • people with an unknown gender
  • people with an unknown region

Exclusion

    Key Trial Info

    Start Date :

    December 28 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    August 31 2021

    Estimated Enrollment :

    5341584 Patients enrolled

    Trial Details

    Trial ID

    NCT05373420

    Start Date

    December 28 2020

    End Date

    August 31 2021

    Last Update

    June 3 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Lisa Cavillot

    Brussels, Belgium, 1000